Related Experiment Video
Updated: Aug 22, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development
Chenping Du1,2, Rani O Whiddett1, Irina Buckle1,3
1Glycation and Diabetes Complications Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba 4102, Australia.
Advanced glycation end products (AGEs) in Western diets may drive Type 1 diabetes (T1D) by activating immune cells via the receptor for AGEs (RAGE). Targeting the AGE-RAGE pathway offers a potential strategy for T1D prevention.
Area of Science:
- Immunology
- Endocrinology
- Nutritional Science
Background:
- Type 1 diabetes (T1D) is an autoimmune disease causing hyperglycemia due to pancreatic beta-cell destruction.
- T1D's increasing prevalence suggests environmental factors play a role alongside genetics.
- Advanced glycation end products (AGEs), common in Western diets, are implicated as an environmental trigger.
Purpose of the Study:
- To investigate the role of the AGE-RAGE axis in Type 1 diabetes pathogenesis.
- To explore the potential of targeting the AGE-RAGE interaction for T1D prevention strategies.
Main Methods:
- Review of existing literature on T1D, AGEs, RAGE, and immune cell interactions.
- Analysis of how AGEs binding to RAGE influences immune cell behavior and beta-cell function.
Main Results:
- RAGE activation by AGEs promotes inflammation and proliferation of T cells (CD8+ and CD4+).
- RAGE activation suppresses regulatory T cell activity, contributing to beta-cell injury.
- The AGE-RAGE interaction is identified as a significant environmental risk factor for T1D.
Conclusions:
- The AGE-RAGE axis is a key environmental contributor to Type 1 diabetes.
- Intervention targeting the AGE-RAGE pathway presents a promising therapeutic avenue for T1D prevention.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

